［1］Sartelli M,Catena F, Ansaloni L,et al.Complicated intra-abdominal infections worldwide: the definitive data of the CIAOW Study［J］.World J Emerg Surg, 2014, 9(1):37.
［2］Mazuski JE, Tessier JM,May AK, et al. The surgical infection society revised guidelines on the management of intra-abdominal infection［J］. Surg Infect, 2017, 18(1):1-76.
［3］黎沾良,陈惠德,汤耀卿.喹诺酮类抗菌药在外科感染中的应用［J］.中国感染与化疗杂志, 2009, 9(2):97-98.
［4］Solomkin JS, Mazuski JE, Bradley JS, et al. Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America［J］. Clin Infect Dis, 2010, 11(1):133-164.
［5］任建安.复杂腹腔感染诊断与治疗策略［J］.中国实用外科杂志， 2011， 9:871-873.
［6］Zhang H, Yang Q, Liao K,et al. Update of incidence and antimicrobial susceptibility trends of Escherichia coli and Klebsiella pneumoniae isolates from Chinese intra-abdominal infection patients［J］. BMC Infect Dis, 2017, 17(1):776.
［7］Kumar A, Roberts D, Wood KE, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock［J］. Crit Care Med, 2006, 34(6):1589-1596.
［8］Membrilla-Fernández E, Sancho-Insenser JJ,Girvent-Montllor M, et al. Effect of initial empiric antibiotic therapy combined with control of the infection focus on the prognosis of patients with secondary peritonitis［J］. Surg Infect, 2014, 15(6):806.
